US authorizes new pancreatic cancer therapy
The US Food and Drug Administration has approved a new drug that could potentially double the survival time for patients with a difficult-to-treat type of cancer.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)